London-based Advent Venture Partners has hired Ian Nicholson as an operating partner for its life sciences division.
Nicholson, pictured, previously spent eight years as CEO of privately held cancer treatment R&D company Chroma Therapeutics.
Before that he was senior vice president for business development at UK biotechnology company Celltech Group, and has worked on licensing, mergers and acquisitions, and market development in the UK, Europe and the US.
Earlier this year Advent Life Sciences’ first fund received repeat commitments from several investors to bring it up to £101.3m.
The fund, which initially closed on £75m in November 2010, is dedicated to investments in early-stage UK and European life sciences companies.
General partner Raj Parekh said at the time, “We appreciate the strong support from our new and existing LPs.
“Advent Life Sciences Fund I has been raised almost entirely from independent financial investors, despite the difficult fundraising environment.
“The Fund has now exceeded our initial target.”
Copyright © 2012 AltAssets